Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Sep 12, 2025

Accession no.
0001628280-25-041985
Filed
Sep 12, 2025
Trade date
Aug 1-29, 2025
Filing delay
42 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $861.57. It was filed 42 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2025Common StockPPurchaseAcquired+13$3.44+$44.725,699,781Direct
Aug 4, 2025Common StockPPurchaseAcquired+13$4.01+$52.135,699,794Direct
Aug 5, 2025Common StockPPurchaseAcquired+13$3.92+$50.965,699,807Direct
Aug 6, 2025Common StockPPurchaseAcquired+13$3.34+$43.425,699,820Direct
Aug 7, 2025Common StockPPurchaseAcquired+13$3.14+$40.825,699,833Direct
Aug 8, 2025Common StockPPurchaseAcquired+13$3.39+$44.075,699,846Direct
Aug 11, 2025Common StockPPurchaseAcquired+13$2.87+$37.315,699,859Direct
Aug 12, 2025Common StockPPurchaseAcquired+13$2.91+$37.835,699,872Direct
Aug 13, 2025Common StockPPurchaseAcquired+13$2.94+$38.225,699,885Direct
Aug 14, 2025Common StockPPurchaseAcquired+13$2.84+$36.925,699,898Direct
Aug 15, 2025Common StockPPurchaseAcquired+13$3.02+$39.265,699,911Direct
Aug 18, 2025Common StockPPurchaseAcquired+13$3.11+$40.435,699,924Direct
Aug 19, 2025Common StockPPurchaseAcquired+13$3.23+$41.995,699,937Direct
Aug 20, 2025Common StockPPurchaseAcquired+2$3.15+$6.35,699,939Direct
Aug 21, 2025Common StockPPurchaseAcquired+13$3.25+$42.255,699,952Direct
Aug 22, 2025Common StockPPurchaseAcquired+13$3.31+$43.035,699,965Direct
Aug 25, 2025Common StockPPurchaseAcquired+13$3.32+$43.165,699,978Direct
Aug 26, 2025Common StockPPurchaseAcquired+13$3.39+$44.075,699,991Direct
Aug 27, 2025Common StockPPurchaseAcquired+13$3.44+$44.725,700,004Direct
Aug 28, 2025Common StockPPurchaseAcquired+13$3.47+$45.115,700,017Direct
Aug 29, 2025Common StockPPurchaseAcquired+13$3.45+$44.855,700,030Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)